Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. ERF.N
ERF.N logo

ERF.N Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
4.10B
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
4.14B
EV/OCF(TTM)
--
P/S(TTM)
2.56
Enerplus Corp produces and develops crude oil and natural gas assets in Canada and the United States. The majority of oil production is derived from the Williston basin, with the Marcellus providing a significant portion of natural gas production. Enerplus acquires the right to use assets through royalties paid to government entities, land owners, and mineral rights owners. Crude oil and natural gas are sold to customers in both countries where assets are held and can be sold either at the well or a fixed destination.
Show More

Events Timeline

No data

No data

News

Businesswire
8.0
03-02Businesswire
Eurofins Scientific SE Stock Buyback Transaction Overview
  • Buyback Overview: Eurofins Scientific SE repurchased a total of 190,000 shares from February 23 to 27, 2026, demonstrating the company's confidence in its stock and aiming to enhance shareholder value.
  • Price Analysis: The weighted average purchase price during the buyback was €67.2772, reflecting a robust strategy amidst market fluctuations, which may bolster investor confidence in its future performance.
  • Market Response: The buyback transactions occurred across different markets (XPARE and CEUX), indicating the company's proactive management of stock liquidity in diverse markets, potentially leading to positive impacts on stock prices.
  • Regulatory Transparency: In compliance with EU Market Abuse Regulation, the company disclosed detailed transaction information on its website, enhancing investor trust in corporate governance and transparency.
Businesswire
8.5
02-26Businesswire
Eurofins Files 2025 Annual and ESG Reports
  • Annual Report Filing: Eurofins submitted its 2025 Annual Report and Environmental, Social, and Governance (ESG) Report to the Luxembourg Stock Exchange on February 26, 2026, reflecting the company's ongoing commitment to transparency and compliance.
  • Broad Service Range: Eurofins is a global leader in testing services across food, environment, pharmaceuticals, and cosmetics, employing over 65,000 staff across more than 950 laboratories, offering over 200,000 analytical methods to meet stringent safety and compliance demands.
  • Technological Investment: The company is continuously investing in digitalization and state-of-the-art laboratory equipment to enhance service quality and turnaround times, ensuring it meets the increasing quality and safety standards of global clients.
  • Strategic Expansion: Eurofins is expanding its technology portfolio and geographic reach through R&D and acquisitions, aiming to leverage the latest advancements in biotechnology and analytical chemistry to provide unique analytical solutions to clients.
Businesswire
8.0
02-23Businesswire
Eurofins Scientific Share Buyback Transaction Overview
  • Transaction Overview: Eurofins Scientific SE executed a share buyback from February 16 to 20, 2026, with a total volume of 180,000 shares, indicating the company's confidence in its stock.
  • Daily Trading Volume: On February 16, 2026, 30,000 shares were repurchased at an average price of €64.67, while on February 19, 67,386 shares were bought back at an average price of €67.38, reflecting fluctuations in market demand for its shares.
  • Market Activity: The buyback transactions occurred across multiple markets, including XPAR and CEUX, demonstrating the company's active presence on various trading platforms aimed at enhancing shareholder value.
  • Compliance Disclosure: In accordance with EU Market Abuse Regulation, Eurofins Scientific has disclosed detailed information about all transactions on its website, ensuring transparency and compliance.
Businesswire
5.0
02-16Businesswire
Eurofins Scientific SE PDMR Transactions Notification
  • Executive Trading Overview: Eurofins Scientific SE has received multiple transaction notifications from Persons Discharging Managerial Responsibilities (PDMR), involving its controlling company Analytical Bioventures S.C.A, indicating active trading behavior among company insiders that may influence market confidence in the stock.
  • Transaction Details Disclosure: Between February 10 and 13, 2026, PDMR acquired a total of 4,000 shares at prices of €67.44, €66.21, €64.08, and €65.21, amounting to a cumulative transaction value of €265,000, reflecting management's confidence in the company's future prospects.
  • Market Reaction Potential: The public disclosure of these transactions complies with European Market Abuse Regulation, which may attract investor attention to the company's stock, especially in the context of active insider buying, potentially leading to positive price movements.
  • Company Background Information: Eurofins Scientific SE is a global leader in bio-analysis, employing over 65,000 staff across more than 950 laboratories, offering over 200,000 analytical methods, showcasing its strong capabilities and market position in the industry.
Businesswire
8.0
02-16Businesswire
Eurofins Scientific Share Buyback Transaction Overview
  • Buyback Overview: Eurofins repurchased a total of 145,000 shares between February 9 and 13, 2026, indicating the company's confidence in its stock and aiming to enhance shareholder value.
  • Daily Trading Volume: The average purchase price during the buyback period was €65.659, reflecting the company's stability amid market fluctuations and expectations for future growth.
  • Market Performance: The buyback transactions were conducted on both XPARE and CEUX markets, demonstrating Eurofins' active management of stock liquidity across multiple trading platforms, thereby enhancing market trust.
  • Compliance Transparency: In accordance with EU Market Abuse Regulation, Eurofins disclosed detailed transaction information on its website, ensuring investors receive transparent information and enhancing corporate governance standards.
Businesswire
5.0
02-10Businesswire
Eurofins Scientific SE PDMR Share Transactions Notification
  • PDMR Trading Notification: Eurofins Scientific SE has received multiple notifications from Persons Discharging Managerial Responsibilities (PDMR), demonstrating the company's commitment to transparency and compliance with European Market Abuse Regulation.
  • Transaction Details: Executive Gavin Hill has made an initial notification of purchasing 430 shares of Eurofins at a price of €67.82 per share, totaling €29,162.97, indicating confidence in the company's future prospects.
  • Market Reaction Potential: Such executive transactions are often viewed as positive signals regarding the company's outlook, which could enhance investor confidence in Eurofins and potentially lead to a favorable impact on its stock price.
  • Company Background: Eurofins, a global leader in bio-analysis, employs over 65,000 staff across 59 countries and offers more than 200,000 analytical methods, with its shares listed on the Euronext Paris Stock Exchange, further solidifying its market position.
Wall Street analysts forecast ERF.N stock price to rise
0 Analyst Rating
Wall Street analysts forecast ERF.N stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
BNP Paribas
Underperform
to
Outperform
upgrade
AI Analysis
2026-01-05
Reason
BNP Paribas
Price Target
AI Analysis
2026-01-05
upgrade
Underperform
to
Outperform
Reason
BNP Paribas upgraded Eurofins Scientific to Outperform from Underperform with a price target of EUR 75, up from EUR 51.50. The company is entering "the sweet spot" of higher growth and margins, the analyst tells investors in a research note.
Piper Sandler
Mark Lear
Buy
Maintains
$184 → $183
2025-04-22
Reason
Piper Sandler
Mark Lear
Price Target
$184 → $183
2025-04-22
Maintains
Buy
Reason

Valuation Metrics

The current forward P/E ratio for Enerplus Corporation (ERF.N) is --, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess Enerplus Corporation's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
Current PE
NaN
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
Current EV/EBITDA
NaN
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
Current PS
NaN
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Whales Holding ERF.N

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Enerplus Corporation (ERF.N) stock price today?

The current price of ERF.N is 0 USD — it has increased 0

What is Enerplus Corporation (ERF.N)'s business?

Enerplus Corp produces and develops crude oil and natural gas assets in Canada and the United States. The majority of oil production is derived from the Williston basin, with the Marcellus providing a significant portion of natural gas production. Enerplus acquires the right to use assets through royalties paid to government entities, land owners, and mineral rights owners. Crude oil and natural gas are sold to customers in both countries where assets are held and can be sold either at the well or a fixed destination.

What is the price predicton of ERF.N Stock?

Wall Street analysts forecast ERF.N stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ERF.N is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Enerplus Corporation (ERF.N)'s revenue for the last quarter?

Enerplus Corporation revenue for the last quarter amounts to 362.04M USD, decreased -12.38

What is Enerplus Corporation (ERF.N)'s earnings per share (EPS) for the last quarter?

Enerplus Corporation. EPS for the last quarter amounts to 0.32 USD, decreased -48.39

How many employees does Enerplus Corporation (ERF.N). have?

Enerplus Corporation (ERF.N) has 404 emplpoyees as of March 10 2026.

What is Enerplus Corporation (ERF.N) market cap?

Today ERF.N has the market capitalization of 4.10B USD.